Welcome to our dedicated page for Gentherm SEC filings (Ticker: THRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating Gentherm’s raw-material risk disclosures or deciphering how climate-seat margins shift between quarters can take hours—each 10-K tops 300 pages and the 10-Q isn’t far behind. For a company whose revenue depends on thermoelectric modules, battery performance solutions, and patient temperature systems, the nuances matter. Our platform tackles this complexity head-on.
Stock Titan’s AI translates every Gentherm filing into clear language, so you can move from reading to decision-making in minutes. Need the Gentherm quarterly earnings report 10-Q filing? We surface segment revenue, R&D expense, and supplier commentary, then link directly to tables for quick verification. Want real-time alerts on Gentherm insider trading Form 4 transactions? You’ll see them seconds after they hit EDGAR, complete with contextual notes on grant price versus market price. Our coverage spans:
- Gentherm annual report 10-K simplified — AI pinpoints battery-thermal R&D and warranty liabilities.
- Gentherm 8-K material events explained — from supply-chain disruptions to new OEM awards.
- Gentherm proxy statement executive compensation — understand how leadership pay aligns with launch schedules.
- Gentherm Form 4 insider transactions real-time & Gentherm executive stock transactions Form 4 — monitor buying or selling before program milestones.
Whether you’re comparing quarter-over-quarter climate seat revenue or gauging how medical-segment growth affects cash flow, you’ll find Gentherm SEC filings explained simply. Use AI-generated charts, keyword search, and expert notes to perform Gentherm earnings report filing analysis or understanding Gentherm SEC documents with AI—all without wading through dense technical jargon.
Gentherm (THRM) reported Q3 results for the period ended September 30, 2025. Product revenue was $386,870, with gross margin of $95,148 and operating income of $23,858. Net income was $14,949, or diluted EPS of $0.49. Interest expense, net, was $3,313, and the effective tax rate was 28.4%.
For the nine months, operating cash flow reached $87,820, ending cash and cash equivalents were $154,250. Total debt was $189,109, primarily the U.S. dollar revolving credit facility at $189,000; $307,938 remained available for additional borrowings. Letters of credit outstanding were $3,062.
The company advanced multi‑region restructuring to optimize its manufacturing footprint. The 2025 Manufacturing Footprint Plan anticipates cash restructuring costs of $3,000–$4,000 for severance and $1,000 of other transition costs, plus $1,000–$2,000 of capital expenditures. The 2025 EMEA Plan expects $4,000–$6,000 for severance and $2,000–$3,000 of other costs, plus $1,000–$2,000 of capital expenditures. The 2025 Asia Plan expects $2,000–$3,000 for severance and $1,000 of other costs, plus $2,000–$3,000 of capital expenditures. As of October 17, 2025, shares outstanding were 30,525,148; year‑to‑date repurchases totaled $10,015, with $110,103 remaining under the authorization.
Gentherm Incorporated reported that it publicly announced its third‑quarter 2025 financial results and updated its full‑year 2025 guidance. The company furnished a press release as Exhibit 99.1.
The company will host a conference call on October 23, 2025 at 8:00 a.m. Eastern Time to discuss results and guidance. Supplemental materials are available on the Events page of the Investors section at www.gentherm.com. The information furnished under Items 2.02 and 7.01 is not deemed filed under the Exchange Act.
Gentherm Inc. insider Sundaram Vishnu, SVP and Chief Technology Officer, reported a sale of 1,242 shares of common stock on 09/26/2025 at a price of $34.81 per share. After the transaction he beneficially owned 21,905 shares. The Form 4 was signed by an authorized representative on 09/30/2025.
Nicholas Breisacher, identified as a Director and Chief Accounting Officer of Gentherm Inc. (THRM), reported a transaction on 08/29/2025 selling 38 shares of common stock at $36.85 per share. Following the sale, he beneficially owns 4,223 shares held directly. The filing was signed by a power of attorney.
Barbara J. Runyon, SVP and CHRO of Gentherm Inc. (THRM), reported an insider sale. On 08/21/2025 she sold 3,348 shares of Gentherm common stock at a weighted average price of $34.82 per share, with sale prices ranging from $34.781 to $34.87. After the sale she beneficially owned 31,316 shares, reported as direct ownership. The Form 4 was signed by a power of attorney on 08/25/2025.
This Form 144 notifies a proposed sale of 3,348 shares of Gentherm Inc. common stock (NASDAQ: THRM) with an aggregate market value of $116,438.1108/21/2025. The shares were acquired on 03/07/2022 as a stock grant from Barbara Runyon (6,005 shares acquired on that date) and payment/consideration is recorded as a stock grant. The filer reports no securities sold in the past three months. Several standard form fields (filer CIK/CCC/contact and the name of the person for whose account the securities are to be sold) are blank in the provided content. The filing includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
FAQ
What is the current stock price of Gentherm (THRM)?
What is the market cap of Gentherm (THRM)?
